Advanced Biomed Inc. ADVB
NASDAQ
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 127.60K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 127.60K | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 127.60K | -- | -- | -- | -- |
| SG&A Expenses | 5.72M | 276.60K | 287.90K | 287.90K | 611.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.05M | 519.80K | 523.90K | 523.90K | 11.30K |
| Operating Income | -4.92M | -519.80K | -523.90K | -523.90K | -11.30K |
| Income Before Tax | -12.52M | -488.90K | -386.90K | -386.90K | 675.60K |
| Income Tax Expenses | -1.20K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.52M | -488.90K | -386.90K | -386.90K | 675.60K |
| Earnings from Discontinued Operations | 13.21M | -- | -- | -- | -1.38M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 695.00K | -488.90K | -386.90K | -386.90K | -701.60K |
| EBIT | -4.92M | -519.80K | -523.90K | -523.90K | -11.30K |
| EBITDA | -4.91M | -510.50K | -475.90K | -475.90K | 53.10K |
| EPS Basic | 0.44 | -0.38 | -0.36 | -0.36 | -0.65 |
| Normalized Basic EPS | -2.06 | -0.24 | -0.22 | -0.22 | 0.39 |
| EPS Diluted | 0.44 | -0.38 | -0.36 | -0.36 | -0.65 |
| Normalized Diluted EPS | -2.06 | -0.24 | -0.22 | -0.22 | 0.39 |
| Average Basic Shares Outstanding | 1.56M | 1.28M | 1.08M | 1.08M | 1.08M |
| Average Diluted Shares Outstanding | 1.56M | 1.28M | 1.08M | 1.08M | 1.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |